Article: Therapy and Prevention for Human Toxocariasis
Microorganisms. 2022 Jan. 22, v. 10, no. 2
2022
Abstract: For the last four decades, knowledge about human toxocariasis with regard to its epidemiology, pathophysiology, clinical spectrum, and imaging or laboratory diagnosis has substantially progressed. Knowledge about specific therapy with anthelmintics has ... ...
Abstract | For the last four decades, knowledge about human toxocariasis with regard to its epidemiology, pathophysiology, clinical spectrum, and imaging or laboratory diagnosis has substantially progressed. Knowledge about specific therapy with anthelmintics has lagged behind. To date, only four drugs are registered for human use, and their efficacy has rarely been assessed in prospective controlled trials. It is likely that the repurposing of potent anthelmintics from veterinary medicine will improve this situation. Due to its wide availability and a lack of major side effects during short regimens, albendazole has become the drug of choice. However, its efficacy should be more precisely assessed. The role of anthelmintics in the treatment of neurological or ocular toxocariasis remains to be clarified. Prophylactic measures in humans or companion animals are efficient and represent first-line treatments for the control of this zoonosis. Unfortunately, their implementation in areas or countries where toxocariasis epidemiology is driven by poverty is quite difficult or unrealistic. |
---|---|
Keywords | albendazole ; epidemiology ; humans ; laboratory diagnosis ; pathophysiology ; poverty ; therapeutics ; toxocariasis ; veterinary medicine ; zoonoses |
Language | English |
Dates of publication | 2022-0122 |
Publishing place | Multidisciplinary Digital Publishing Institute |
Document type | Article |
ZDB-ID | 2720891-6 |
ISSN | 2076-2607 |
ISSN | 2076-2607 |
DOI | 10.3390/microorganisms10020241 |
Database | NAL-Catalogue (AGRICOLA) |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.